
Aimee J. Li
Supervisory Patent Examiner (ID: 15085, Phone: (571)272-4169 , Office: P/2183 )
| Most Active Art Unit | 2183 |
| Art Unit(s) | 2137, 2100, 2183, 2195 |
| Total Applications | 539 |
| Issued Applications | 378 |
| Pending Applications | 21 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20372737
[patent_doc_number] => 12480164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => DNA methylation biomarkers for early detection of cervical cancer
[patent_app_type] => utility
[patent_app_number] => 17/299132
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7644
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299132 | DNA methylation biomarkers for early detection of cervical cancer | Feb 3, 2020 | Issued |
Array
(
[id] => 18227293
[patent_doc_number] => 20230066287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => BIOMARKERS FOR RENAL CELL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/423029
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423029 | BIOMARKERS FOR RENAL CELL CARCINOMA | Jan 15, 2020 | Pending |
Array
(
[id] => 17657507
[patent_doc_number] => 20220177972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHYLATION MODIFICATION-BASED TUMOR MARKER STAMP-EP4
[patent_app_type] => utility
[patent_app_number] => 17/309901
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309901 | METHYLATION MODIFICATION-BASED TUMOR MARKER STAMP-EP4 | Dec 29, 2019 | Pending |
Array
(
[id] => 18461666
[patent_doc_number] => 11685950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Method of diagnosing and treating acute rejection in kidney transplant patients
[patent_app_type] => utility
[patent_app_number] => 16/727281
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7044
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16727281
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/727281 | Method of diagnosing and treating acute rejection in kidney transplant patients | Dec 25, 2019 | Issued |
Array
(
[id] => 16269201
[patent_doc_number] => 20200270688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION, METHODS OF DETECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/720403
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720403 | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 16073193
[patent_doc_number] => 20200190583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => Methods and Compositions for Sequentially Detecting Targets
[patent_app_type] => utility
[patent_app_number] => 16/713760
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713760 | Methods and compositions for sequentially detecting targets | Dec 12, 2019 | Issued |
Array
(
[id] => 16238672
[patent_doc_number] => 20200255906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA
[patent_app_type] => utility
[patent_app_number] => 16/709780
[patent_app_country] => US
[patent_app_date] => 2019-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16709780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/709780 | Extract from a body fluid comprising a micro RNA | Dec 9, 2019 | Issued |
Array
(
[id] => 16269200
[patent_doc_number] => 20200270687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 16/707584
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707584 | Cystic fibrosis transmembrane conductance regulator gene mutations | Dec 8, 2019 | Issued |
Array
(
[id] => 17299981
[patent_doc_number] => 20210395820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHOD OF EVALUATING FEMALE REPRODUTIVE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/293281
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293281 | METHOD OF EVALUATING FEMALE REPRODUTIVE FUNCTION | Dec 5, 2019 | Abandoned |
Array
(
[id] => 17428797
[patent_doc_number] => 20220056505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Methods for Detecting Cell Wall-Deficient Bacteria (CWDB) in Biological Samples
[patent_app_type] => utility
[patent_app_number] => 17/299885
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299885 | Methods for Detecting Cell Wall-Deficient Bacteria (CWDB) in Biological Samples | Dec 4, 2019 | Pending |
Array
(
[id] => 20343354
[patent_doc_number] => 12467077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Compositions and methods for DNA modification detection
[patent_app_type] => utility
[patent_app_number] => 17/293869
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 14710
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293869 | Compositions and methods for DNA modification detection | Nov 17, 2019 | Issued |
Array
(
[id] => 18643499
[patent_doc_number] => 11767560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Diagnostic and treatment method for endometrial cavity distorting uterine leiomyoma using microRNA
[patent_app_type] => utility
[patent_app_number] => 16/565443
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 3612
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16565443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/565443 | Diagnostic and treatment method for endometrial cavity distorting uterine leiomyoma using microRNA | Nov 14, 2019 | Issued |
Array
(
[id] => 20414388
[patent_doc_number] => 12497661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Method of improving prediction of response for cancer patients treated with immunotherapy
[patent_app_type] => utility
[patent_app_number] => 16/685439
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 8962
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/685439 | Method of improving prediction of response for cancer patients treated with immunotherapy | Nov 14, 2019 | Issued |
Array
(
[id] => 17627678
[patent_doc_number] => 20220162693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => MASSIVELY PARALLEL SEQUENCING USING UNLABELED NUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/291962
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291962 | MASSIVELY PARALLEL SEQUENCING USING UNLABELED NUCLEOTIDES | Nov 10, 2019 | Pending |
Array
(
[id] => 15899181
[patent_doc_number] => 20200149109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Method to Predict Response to Neuropsychiatric Drugs Using Variation in the Serotonin 7 Receptor (HTR7) Gene
[patent_app_type] => utility
[patent_app_number] => 16/678855
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/678855 | Method to predict response to neuropsychiatric drugs using variation in the serotonin 7 receptor (HTR7) gene | Nov 7, 2019 | Issued |
Array
(
[id] => 17801283
[patent_doc_number] => 11415577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Method of detecting bio-material
[patent_app_type] => utility
[patent_app_number] => 16/669181
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 3981
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16669181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/669181 | Method of detecting bio-material | Oct 29, 2019 | Issued |
Array
(
[id] => 16177310
[patent_doc_number] => 20200224278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING EPITHELIAL CELL DNA
[patent_app_type] => utility
[patent_app_number] => 16/665731
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16665731
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/665731 | Compositions comprising ZDHHC1 DNA in a complex | Oct 27, 2019 | Issued |
Array
(
[id] => 16223152
[patent_doc_number] => 20200248268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Method For Estimating A Risk For A Subject Suffering From Urothelial Carcinoma And Kit Thereof
[patent_app_type] => utility
[patent_app_number] => 16/658754
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16658754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/658754 | Method For Estimating A Risk For A Subject Suffering From Urothelial Carcinoma And Kit Thereof | Oct 20, 2019 | Abandoned |
Array
(
[id] => 17913611
[patent_doc_number] => 20220316006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PLASMA AND CEREBROSPINAL FLUID MIRNA BIOMARKERS IN INTRACEREBRAL AND SUBARACHNOID HEMORRHAGE
[patent_app_type] => utility
[patent_app_number] => 17/286411
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286411 | PLASMA AND CEREBROSPINAL FLUID MIRNA BIOMARKERS IN INTRACEREBRAL AND SUBARACHNOID HEMORRHAGE | Oct 15, 2019 | Abandoned |
Array
(
[id] => 17830530
[patent_doc_number] => 20220267834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => MOLECULAR MARKER COMBINATION LINKED TO QUANTITATIVE TRAITS OF TEA PLANT (+)-CATECHIN CONTENT
[patent_app_type] => utility
[patent_app_number] => 17/254302
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254302 | MOLECULAR MARKER COMBINATION LINKED TO QUANTITATIVE TRAITS OF TEA PLANT (+)-CATECHIN CONTENT | Oct 13, 2019 | Abandoned |